preparing to fend off threats to a blockbuster drug

Page | 1

Preparing to Fend Off Threats to a Blockbuster Drug

CASE STUDY

PREPARING TO FEND OFF THREATS TO A BLOCKBUSTER DRUG WWW.FULD.COM

Competitors Set Their Sights on the Market

A biologic drug, with annual sales over $1 billion, offered a tempting target for nearly a dozen pharma companies around the world seeking to develop alternatives. The drug’s manufacturer, one of the largest pharmaceutical companies in the world, wanted to track the nature and progress of competitor products and the strategies their makers were pursuing. In this complex market, Fuld + Company’s superior competitive intelligence, combined with deep knowledge of the drug’s therapeutic area, provided the company with a range of countermeasures it could take to fend off the many threats to its blockbuster product.

Case Overview

http://www.fuld.com/


Threats from All Angles Key Business Challenges

Some of the largest and most successful companies in the world were pursuing a variety of drug types – small molecule, biologics, and biosimilars – and a variety of avenues for attacking the mechanism of the disease. A number of these drugs were already in Phase III clinical trials, with possible launch not far in the future. In addition, some of the drugs in development were intended to provide clinical advantage over our client’s product.



Calling for Reinforcements Key Business Challenges

Faced with the depth and breadth of the competition and the value of the threatened product, the company wanted to augment its considerable in-house competitive intelligence capability as well as benefit from the perspective and advice of a third party with deep industry knowledge.



Monitoring the Market and Anticipate Competitor Moves The Fuld Approach

Working in close collaboration with the client and leveraging the best available sources of information, Fuld + Company was able to:

Continuously monitor market and clinical developments around the world

Synthesize and analyze raw data and convert it into concise customized intelligence

Provide timely and unambiguous early warning of potential threats and opportunities via immediate notification, regular updates and periodic reports

Generate pipeline analyses and product profiles of competitors

Analyze clinical and market data to build timelines for development and launch of competing products

Participate in and conduct an internal war game designed to uncover how companies competing in the market space were likely to respond to each other’s strategic moves



Preparing to Prevail Key Business Impact

The company now has a detailed understanding of the products and strategies being pursued by the many competitors in this complex market and a timeline of impending events. Armed with that knowledge and the insight and recommendations provided by Fuld + Company regarding marketing and R&D efforts, the company is well prepared to make strategic and tactical moves designed to enhance the drug’s dominance of the market.



A Global Challenge The Fuld Review

Keeping up with a fast-moving, market around the world requires global reach. With offices in London, Boston, Dalian (China), Singapore, and Manila, Fuld brought the international presence and the language skills necessary for addressing the top five European markets, the U.S., and China. Our capabilities and footprint, combined with those of the client, created synergies that moved the work rapidly forward while ensuring the depth of analysis such global markets require.



Why Choose Fuld

Fuld + Company doesn’t just provide information; they explain what it means to our organization, incite thinking, and make valuable recommendations. Many people tend to say what they think you want to hear, but Fuld gives us an honest and professional perspective. They are passionate about what they do and they clearly enjoy doing it.

− CI Director from the company

Client Testimonial



Think a similar solution could work for your organization?

CONTACT US fuld.com/solutions


http://bit.ly/contact-LS



NORTH AMERICA

Global US Headquarters 131 Oliver Street , 3rd Floor | Boston, MA 02110 | USA | +1 617 492 5900

EUROPE London: 20 Conduit Street | London W1S 2XW | United Kingdom | +44 (0) 7659 6999

ASIA PACIFIC Manila: 3402 One Corporate Centre | Julia Vargas cor. Meralco Ave. | Ortigas Center, Pasig City | Philippines | +63 (0) 706 3292

About Fuld + Company

WHO WE ARE

Since 1979 Fuld + Company have pioneered competitive intelligence, and today we work with leading companies worldwide to deliver the competitive and market insights they need to make better business decisions. We don’t rest on our history and past successes. This means working hard to deliver uncompromising analysis that generates sound advice and earns us enduring partnerships with our clients.

WHY CHOOSE US

We are driven to expose our clients to insights about their industry, their competition and a changing market; designed to help avoid surprises and industry shocks. Through deep research, penetrating analysis and strategic gaming + advisory expertise, our team of professionals help you identify and solve tactical and strategic challenges. We help reduce the risks associated with business-critical decision making.

COMPETITIVE + MARKET INTELLIGENCE

Competitive + Brand Insights

War Games / Competitive Simulations

Market Analysis, Share + Sizing

Supply Chain Mapping

GO-TO-MARKET STRATEGY

Brand + Product Positioning / Launch Support

Product Portfolio Roadmap

New Market Entry / Segmentation

Value Chain Analysis

Life Cycle Management

Win / Loss Bid Support

CORPORATE STRATEGIC PLANNING

Early Warning + Scenario Planning

Sales Force Effectiveness

Merger/Acquisition + Licensing

Innovation Strategy

Business Model / Industry Convergence



http://www.fuld.com/services/




preparing to fend off threats to a blockbuster drug

Health & Medicine

fuld fuld

blockbuster product

biologic drug

fuld approach

fuld review

blockbuster drug case

market data

complex market